1. Home
  2. TEVA
  3. TEVA News

Latest Teva Pharmaceutical Industries Limited (TEVA) News on February 22, 2025

Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease
TEVA

GlobeNewswire

16 hours ago

Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease

TEVA

MT Newswires

a day ago

Teva Pharmaceutical US Affiliate, Alvotech Selarsdi Injection Now Available in US

Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
TEVA

GlobeNewswire

2 days ago

Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.

Billionaire Stanley Druckenmiller Dumped Duquesne's Entire Stake in Broadcom and Bought One of Wall Street's Hottest Drug Stocks Hand Over Fist
TEVA

Motley Fool

3 days ago

Billionaire Stanley Druckenmiller Dumped Duquesne's Entire Stake in Broadcom and Bought One of Wall Street's Hottest Drug Stocks Hand Over Fist

TEVA

MT Newswires

3 days ago

Teva Pharmaceutical Industries Insider Sold Shares Worth $1,279,661, According to a Recent SEC Filing

Is Teva Pharmaceutical (TEVA) Trading at a Discount?
TEVA

Insider Monkey

3 days ago

Is Teva Pharmaceutical (TEVA) Trading at a Discount?

Teva to Host Conference Call on February 24, 2025 to Discuss New Data Presented for Duvakitug (anti-TL1A) Positive Phase 2b results at the 20th Annual Congress of the European Crohn's and Colitis Organisation (ECCO)
TEVA

GlobeNewswire

4 days ago

Teva to Host Conference Call on February 24, 2025 to Discuss New Data Presented for Duvakitug (anti-TL1A) Positive Phase 2b results at the 20th Annual Congress of the European Crohn's and Colitis Organisation (ECCO)

FDA To Review Teva and Alvotech Drug That Could Compete With Regeneron's Eylea
TEVA

Investopedia

4 days ago

FDA To Review Teva and Alvotech Drug That Could Compete With Regeneron's Eylea

TEVA

MT Newswires

4 days ago

Alvotech, Teva Pharmaceutical's Bionsimlar Eye Disorder Potential Treatment Accepted for FDA Review

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)
TEVA

GlobeNewswire

5 days ago

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)

TEVA

GuruFocus.com

8 days ago

Stanley Druckenmiller's Strategic Moves: A Closer Look at Teva Pharmaceutical Industries Ltd

TEVA

MT Newswires

8 days ago

Teva Pharmaceutical Industries Insider Sold Shares Worth $2,886,565, According to a Recent SEC Filing

Axsome Stock Surges 20% on Auvelity Patent Settlement With Teva
TEVA

Zacks

11 days ago

Axsome Stock Surges 20% on Auvelity Patent Settlement With Teva

Axsome Therapeutics Resolves Generic Patent Litigation With Teva Over Depression Drug, Analyst Maintains Axsome As 'Top Pick For 2025'
TEVA

Benzinga

12 days ago

Axsome Therapeutics Resolves Generic Patent Litigation With Teva Over Depression Drug, Analyst Maintains Axsome As 'Top Pick For 2025'

TEVA

MT Newswires

12 days ago

Update: Axsome Therapeutics Shares Rise Following Deal to Settle Auvelity Patent Litigation With Teva

TEVA

MT Newswires

12 days ago

Axsome, Teva Settle Auvelity Patent Litigation

TEVA

Argus Research

12 days ago

Weekly Stock List

Axsome secures top drug’s future with Teva patent settlement
TEVA

BioPharma Dive

12 days ago

Axsome secures top drug’s future with Teva patent settlement

TEVA

MT Newswires

15 days ago

Teva Pharmaceutical Industries Files Mixed Shelf Registration

Teva Pharmaceutical Industries Full Year 2024 Earnings: EPS Misses Expectations
TEVA

Simply Wall St.

16 days ago

Teva Pharmaceutical Industries Full Year 2024 Earnings: EPS Misses Expectations

TEVA

MT Newswires

18 days ago

Saverone 2014 Wins Contract To Equip Teva Pharmaceutical's 50-Truck Fleet With Safety System

This Drug Stock Sits On A Strong Earnings Foundation As It Tests New Entry
TEVA

Investor's Business Daily

22 days ago

This Drug Stock Sits On A Strong Earnings Foundation As It Tests New Entry

TEVA

Argus Research

22 days ago

Analyst Report: Teva Phar Inds Lt

TEVA

Argus Research

22 days ago

Market Digest: TEVA, AAPL, CMA, FCX, FLEX, LAZ, TMUS, MA

Teva Pharmaceutical Industries Ltd (TEVA) Q4 2024 Earnings Call Highlights: Strong Revenue ...
TEVA

GuruFocus.com

23 days ago

Teva Pharmaceutical Industries Ltd (TEVA) Q4 2024 Earnings Call Highlights: Strong Revenue ...

TEVA Stock Down 14% Despite Q4 Earnings & Revenues Beat Estimates
TEVA

Zacks

23 days ago

TEVA Stock Down 14% Despite Q4 Earnings & Revenues Beat Estimates

Why Teva Pharmaceuticals (TEVA) Crashed on Wednesday?
TEVA

Insider Monkey

23 days ago

Why Teva Pharmaceuticals (TEVA) Crashed on Wednesday?

TEVA

Morningstar Research

24 days ago

Analyst Report: Teva Pharmaceutical Industries Limited

Why Teva Pharmaceutical Stock Is Sinking Today
TEVA

Motley Fool

24 days ago

Why Teva Pharmaceutical Stock Is Sinking Today

Teva Pharmaceutical Industries (TEVA) Q4 2024 Earnings Call Transcript
TEVA

Motley Fool

24 days ago

Teva Pharmaceutical Industries (TEVA) Q4 2024 Earnings Call Transcript

TEVA

MT Newswires

24 days ago

Sector Update: Health Care Stocks Softer in Afternoon Trading

Teva Stock Dives 14%. 'We're Victims Of Our Own Success,' Says CEO.
TEVA

Investor's Business Daily

24 days ago

Teva Stock Dives 14%. 'We're Victims Of Our Own Success,' Says CEO.

Trump Media's Truth.Fi, T-Mobile, Teva: Market Minute
TEVA

Yahoo Finance Video

24 days ago

Trump Media's Truth.Fi, T-Mobile, Teva: Market Minute

TEVA

MT Newswires

24 days ago

Update: Teva Pharmaceutical Shares Drop After Q4 Non-GAAP Earnings, Revenue Fall

Teva Pharmaceutical Posts Lower Revenue. Stock Slips.
TEVA

Investor's Business Daily

24 days ago

Teva Pharmaceutical Posts Lower Revenue. Stock Slips.

TEVA

MT Newswires

24 days ago

Sector Update: Health Care Stocks Mixed Pre-Bell Wednesday

TEVA

MT Newswires

24 days ago

Sector Update: Health Care

TEVA

MT Newswires

24 days ago

Teva Pharmaceutical Q4 Non-GAAP Earnings, Revenue Fall; 2025 Outlook Issued

Teva Delivers Second Consecutive Year of Growth; Announces Strong Financial Results in Fourth Quarter and Full Year 2024, Led by Generics Performance and Innovative Portfolio Growth
TEVA

GlobeNewswire

24 days ago

Teva Delivers Second Consecutive Year of Growth; Announces Strong Financial Results in Fourth Quarter and Full Year 2024, Led by Generics Performance and Innovative Portfolio Growth

TEVA

MT Newswires

a month ago

Alvotech, Teva Filing for Inflammatory Treatment Candidate Accepted for FDA Review

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)
TEVA

GlobeNewswire

a month ago

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)

FDA adds boxed warning to multiple sclerosis drugs after anaphylaxis cases
TEVA

Pharmaceutical Technology

a month ago

FDA adds boxed warning to multiple sclerosis drugs after anaphylaxis cases

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks
TEVA

TipRanks

a month ago

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks

TEVA

MT Newswires

a month ago

Update: Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks

Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations
TEVA

Yahoo Finance

a month ago

Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations

How Teva Pharmaceuticals is thinking about Trump's return: CEO
TEVA

Yahoo Finance Video

a month ago

How Teva Pharmaceuticals is thinking about Trump's return: CEO

Amicus Posts Preliminary 2024 Results, Issues 2025 Outlook
TEVA

Zacks

a month ago

Amicus Posts Preliminary 2024 Results, Issues 2025 Outlook

TEVA

MT Newswires

a month ago

Teva Pharmaceuticals International Enters Collaboration to Commercialize Eye Disease Treatment

Teva Announces Collaboration to Commercialize Formycon’s Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in Israel
TEVA

GlobeNewswire

a month ago

Teva Announces Collaboration to Commercialize Formycon’s Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in Israel

TEVA

MT Newswires

a month ago

Teva Pharmaceutical, Samsung Bioepis to Commercialize Epysqli in US

Samsung Bioepis and Teva Enter into a Strategic Partnership for Commercialization of EPYSQLI® (eculizumab-aagh) in the United States
TEVA

GlobeNewswire

a month ago

Samsung Bioepis and Teva Enter into a Strategic Partnership for Commercialization of EPYSQLI® (eculizumab-aagh) in the United States

Biotech Stock Roundup: NMRA Plunges on Study Failure, HOTH, VIR Soar on Study Data & More
TEVA

Zacks

a month ago

Biotech Stock Roundup: NMRA Plunges on Study Failure, HOTH, VIR Soar on Study Data & More

Catalyst Pharmaceuticals Settles Patent Litigation Case With Teva Pharmaceutical
TEVA

Benzinga

a month ago

Catalyst Pharmaceuticals Settles Patent Litigation Case With Teva Pharmaceutical

CPRX Stock Rises 17% on Settling Firdapse Patent Litigation With Teva
TEVA

Zacks

a month ago

CPRX Stock Rises 17% on Settling Firdapse Patent Litigation With Teva

IBD Tech Leader Catalyst Rockets After Striking A Key Deal With Teva
TEVA

Investor's Business Daily

a month ago

IBD Tech Leader Catalyst Rockets After Striking A Key Deal With Teva

TEVA

MT Newswires

a month ago

Sector Update: Health Care Stocks Advance Late Afternoon

TEVA

MT Newswires

a month ago

Sector Update: Health Care Stocks Higher in Afternoon Trading

Why Teva Pharmaceuticals Industries Ltd. (TEVA) Crashed Yesterday
TEVA

Insider Monkey

2 months ago

Why Teva Pharmaceuticals Industries Ltd. (TEVA) Crashed Yesterday

TEVA

Argus Research

2 months ago

Weekly Stock List

Teva Pharmaceutical Industries Ltd (TEVA) Ends Trading Week Defying Market Bloodbath
TEVA

Insider Monkey

2 months ago

Teva Pharmaceutical Industries Ltd (TEVA) Ends Trading Week Defying Market Bloodbath

TEVA

MT Newswires

2 months ago

Teva Pharmaceutical Industries Insider Sold Shares Worth $6,294,031, According to a Recent SEC Filing

Billionaire Stanley Druckenmiller Is Selling Nvidia and Palantir and Piling Into One of Wall Street's Hottest Drug Stocks Ahead of 2025
TEVA

Motley Fool

2 months ago

Billionaire Stanley Druckenmiller Is Selling Nvidia and Palantir and Piling Into One of Wall Street's Hottest Drug Stocks Ahead of 2025

Why Teva Pharmaceuticals Industries (TEVA) Skyrocketed?
TEVA

Insider Monkey

2 months ago

Why Teva Pharmaceuticals Industries (TEVA) Skyrocketed?

Teva to Present at the 43rd Annual J.P. Morgan Healthcare Conference
TEVA

GlobeNewswire

2 months ago

Teva to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
TEVA

Insider Monkey

2 months ago

Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory

Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025
TEVA

GlobeNewswire

2 months ago

Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025

Pharma Stock Roundup: PFE's 2025 Outlook, MRK & ABBV's M&A Deals
TEVA

Zacks

2 months ago

Pharma Stock Roundup: PFE's 2025 Outlook, MRK & ABBV's M&A Deals

My Top 10 Portfolio Holdings for 2025
TEVA

Motley Fool

2 months ago

My Top 10 Portfolio Holdings for 2025

Teva price target raised to $28 from $26 at UBS
TEVA

TipRanks

2 months ago

Teva price target raised to $28 from $26 at UBS

Jim Cramer on Teva Pharmaceutical Industries (TEVA): A Game-Changer for Intractable Disease Treatments?
TEVA

Insider Monkey

2 months ago

Jim Cramer on Teva Pharmaceutical Industries (TEVA): A Game-Changer for Intractable Disease Treatments?

TEVA

MT Newswires

2 months ago

Teva Pharmaceutical Stock Positioned for Even Better Performance in 2025, UBS Says

TEVA

MT Newswires

2 months ago

BofA Securities Raises Price Target on Teva Pharmaceutical Industries to $25 From $23, Keeps Buy Rating

SNY, TEVA Stocks Jump on Encouraging Data From IBD Drug Study
TEVA

Zacks

2 months ago

SNY, TEVA Stocks Jump on Encouraging Data From IBD Drug Study

Fed decision looms, Nvidia looks to rebound: Yahoo Finance
TEVA

Yahoo Finance Video

2 months ago

Fed decision looms, Nvidia looks to rebound: Yahoo Finance

Strength Seen in Teva Pharmaceutical Industries (TEVA): Can Its 26.5% Jump Turn into More Strength?
TEVA

Zacks

2 months ago

Strength Seen in Teva Pharmaceutical Industries (TEVA): Can Its 26.5% Jump Turn into More Strength?

Sanofi and Teva’s duvakitug meets primary endpoints in Phase IIb trial
TEVA

Clinical Trials Arena

2 months ago

Sanofi and Teva’s duvakitug meets primary endpoints in Phase IIb trial

TEVA

Morningstar Research

2 months ago

Analyst Report: Teva Pharmaceutical Industries Limited

Teva and Sanofi jump on experimental bowel disease drug success
TEVA

Yahoo Finance Video

2 months ago

Teva and Sanofi jump on experimental bowel disease drug success

Teva Catapults 26%, Hitting A Six-Year High, After Scoring A Win With Sanofi-Tied Drug
TEVA

Investor's Business Daily

2 months ago

Teva Catapults 26%, Hitting A Six-Year High, After Scoring A Win With Sanofi-Tied Drug

Teva, Sanofi Say Inflammatory Bowel Disease Drug Study Meets Primary Endpoints
TEVA

MT Newswires

2 months ago

Teva, Sanofi Say Inflammatory Bowel Disease Drug Study Meets Primary Endpoints

Positive Test Results Reported for Teva-Sanofi Drug for Ulcerative Colitis, Crohn's
TEVA

Investopedia

2 months ago

Positive Test Results Reported for Teva-Sanofi Drug for Ulcerative Colitis, Crohn's

TEVA

MT Newswires

2 months ago

Update: Teva, Sanofi Shares Jump as Phase 2B Duvakitug Study Meets Primary Endpoints in Inflammatory Bowel Disease

Teva Stock Soars 19% as Game-Changing IBD Drug Duvakitug Crushes Trial Expectations
TEVA

GuruFocus.com

2 months ago

Teva Stock Soars 19% as Game-Changing IBD Drug Duvakitug Crushes Trial Expectations

Teva, Cloudflare, Sanofi: Trending Tickers
TEVA

Yahoo Finance Video

2 months ago

Teva, Cloudflare, Sanofi: Trending Tickers

Teva Soars, Sanofi Gains on Strong Trial Results for IBD Treatment
TEVA

The Wall Street Journal

2 months ago

Teva Soars, Sanofi Gains on Strong Trial Results for IBD Treatment

Teva Catapults 20%, Nearing A Five-Year High, After Scoring A Win With Sanofi-Tied Drug
TEVA

Investor's Business Daily

2 months ago

Teva Catapults 20%, Nearing A Five-Year High, After Scoring A Win With Sanofi-Tied Drug

Teva Shares Soar on Early Bowel Disease Drug Data
TEVA

Barrons.com

2 months ago

Teva Shares Soar on Early Bowel Disease Drug Data

Why Are Teva And Sanofi Stocks Trading Higher On Tuesday?
TEVA

Benzinga

2 months ago

Why Are Teva And Sanofi Stocks Trading Higher On Tuesday?

TEVA

MT Newswires

2 months ago

Teva, Sanofi Say Phase 2B Duvakitug Study Meets Primary Endpoints in Inflammatory Bowel Disease

Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease
TEVA

GlobeNewswire

2 months ago

Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease

Teva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured Patients
TEVA

GlobeNewswire

2 months ago

Teva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured Patients

TEVA

MT Newswires

3 months ago

Teva Pharmaceutical to Divest Japanese Venture to JKI

Teva Announces Agreement to Divest Teva-Takeda, its Business Venture in Japan
TEVA

GlobeNewswire

3 months ago

Teva Announces Agreement to Divest Teva-Takeda, its Business Venture in Japan

Teva reports positive outcomes from episodic migraine trial in young patients
TEVA

Clinical Trials Arena

3 months ago

Teva reports positive outcomes from episodic migraine trial in young patients

TEVA

MT Newswires

3 months ago

Teva Pharmaceutical Says Migraine Prevention Drug Shows Efficacy in Younger Patients

Teva Presents Positive Efficacy and Safety Data of AJOVY® (fremanezumab) for the Prevention of Episodic Migraine in Children and Adolescents from Phase 3 SPACE Trial
TEVA

GlobeNewswire

3 months ago

Teva Presents Positive Efficacy and Safety Data of AJOVY® (fremanezumab) for the Prevention of Episodic Migraine in Children and Adolescents from Phase 3 SPACE Trial

TEVA Stock Down 10% in a Month: Should You Buy the Dip?
TEVA

Zacks

3 months ago

TEVA Stock Down 10% in a Month: Should You Buy the Dip?

Teva to Present at the 7th Annual Evercore ISI HealthCONx Conference
TEVA

GlobeNewswire

3 months ago

Teva to Present at the 7th Annual Evercore ISI HealthCONx Conference

Teva Pharmaceutical (TEVA): The Global Leader in Affordable Medicine Under $25
TEVA

Insider Monkey

3 months ago

Teva Pharmaceutical (TEVA): The Global Leader in Affordable Medicine Under $25

TEVA

Argus Research

3 months ago

Weekly Stock List

Share on Social Networks: